Harold S. Bernstein
President of Research & Development and Chief Medical OfficerDr. Harold S. Bernstein, M.D., PhD., is President of Research & Development and Chief Medical Officer at Maze Therapeutics, Inc. since October 2022. He served as Senior Vice President of Worldwide Research and Development, Chief Medical Officer & Head of Global Clinical Development of BioMarin Pharmaceutical Inc. from October 2021 to September 2022. Dr. Bernstein joined the BioMarin Pharmaceutical Inc. in October 2021. Most recently, Dr. Bernstein was Head of Translational Medicine and Vice President of Global Medicines Development and Medical Affairs at Vertex from October 2017 to September 2021. Dr. Bernstein served as Head of Cardiometabolic Diseases Early Clinical Development and Executive Director at Merck & Co., Inc., a multinational pharmaceutical company, from January 2013 to September 2017. He was Professor of Pediatric Cardiology and a senior investigator at the Cardiovascular Research Institute and the Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco (UCSF) from January 1997 to June 2013. He also served as attending physician at UCSF Benioff Children's Hospital in Pediatric Cardiology and in Cardiovascular Genetics. Dr. Bernstein holds appointments as attending cardiologist at Mount Sinai Kravis Children's Hospital in New York, as well as Adjunct Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai Since July 2013. He studied biomedical science, human genetics and medicine at the Icahn School of Medicine at Mount Sinai., earning an MPhil, PhD(Human Genetics) and MD. He completed a pediatric residency, cardiology fellowship and postdoctoral fellowship at UCSF and earned an A.B. in biological sciences from Harvard College.
Positions
- Company NameMaze Therapeutics, Inc.Stock CodeMAZEPositionPresident of Research & Development and Chief Medical OfficerColleagues
- JVJason V. ColomaCEO & Director
- HHHerve HoppenotChairman of the Board
- MTMisbah TahirCFO & Principal Accounting Officer
- VVVipin VijayakumarSenior Vice President of Technology and Business Operations
- MHMaarten HoekChief Scientific Officer
- DKDaniel K. SpiegelmanIndependent Non-Employee Director
- JEJonathan E. LimIndependent Non-Employee Director
- CJCharles J. HomcyDirector
